Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,533 | -4,817 | -2,683 | -11,631 | -10,362 |
| Depreciation Amortization | 0 | 0 | 0 | 353 | 167 |
| Other Working Capital | 372 | 765 | 236 | -849 | -498 |
| Other Operating Activity | 1,575 | 1,190 | 726 | 9,629 | 9,299 |
| Operating Cash Flow | $-4,586 | $-2,861 | $-1,721 | $-2,498 | $-1,395 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -335 | -235 |
| Common Stock Issued | 9,247 | 9,246 | 9,246 | 6,424 | 6,268 |
| Other Financing Activity | 0 | 0 | 0 | 260 | 160 |
| Financing Cash Flow | $9,247 | $9,246 | $9,246 | $6,349 | $6,193 |
| Beginning Cash Position | 3,869 | 3,869 | 3,869 | 18 | 18 |
| End Cash Position | 8,530 | 10,254 | 11,394 | 3,869 | 4,817 |
| Net Cash Flow | $4,661 | $6,385 | $7,525 | $3,851 | $4,799 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,586 | -2,861 | -1,721 | -2,498 | -1,395 |
| Free Cash Flow | -4,586 | -2,861 | -1,721 | -2,498 | -1,395 |